Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Roof who wrote (1190)	1/11/2000 1:37:00 AM
From: billkirn	Read Replies (1) \| Respond to of 1972

Pretty exciting to have options you buy at 2 go to 22+. Plan to buy the stock at 12.5 per share. What to make of this 30% move today. Must be the visibility of the genome project completions. Getting a lot of press and tv coverage. Of course I wonder if there is something really brewing behind the scenes. Alan did not provide any indication that a big deal was in the offing, so maybe just the culmination of the last years of development. I would hope VICAL could pull a HGSI move over the next few months. A 5x would be just right to reward the long term holders. Bill